By Jeff Overley ( May 13, 2014, 9:37 PM EDT) -- The U.S. Food and Drug Administration on Tuesday released its most detailed guidance yet on evidence needed to prove that biosimilars are close matches of their brand-name counterparts, providing more clarity on the scientific expectations that will determine the cost of bringing generic biologics to market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.